NOX — Noxopharm Share News
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- AU$15.05m
- AU$19.33m
- AU$1.45m
Australia Stock Exchange release from NOXOPHARM : December 2021 Quarterly Activities Report and Appendix 4C
Australia Stock Exchange release from NOXOPHARM : PRE_NR Ends: 09:03:25
Australia Stock Exchange release from NOXOPHARM : Noxopharm Presents at H.C. Wainwright BioConnect Conference
Australia's Noxopharm rises as co gets tax refund
Brief: Noxopharm Receives A$5.865 Mln R & D Tax Rebate Under Australian Govt's Research And Development Tax Incentive Scheme During FY21
Australia Stock Exchange release from NOXOPHARM : PRE_NR Ends: 09:27:23
Australia Stock Exchange release from NOXOPHARM : Noxopharm Receives A$5.865M R & D Tax Rebate
Australia's Noxopharm hits one-month high after CEO appointment
Brief: Noxopharm Appoints Gisela Mautner As Chief Executive Officer
Australia Stock Exchange release from NOXOPHARM : Noxopharm Announces Leadership Transition
Australia Stock Exchange release from NOXOPHARM : PRE_NR Ends: 09:02:54
Australia Stock Exchange release from NOXOPHARM : Noxopharm DARRT-2 Cancer Trial Update
Australia Stock Exchange release from NOXOPHARM : PRE_NR Ends: 10:03:58
Australia Stock Exchange release from NOXOPHARM : Notification of cessation of securities - NOX
Australia Stock Exchange release from NOXOPHARM : Change of Director's Interest Notice - GK
Australia Stock Exchange release from NOXOPHARM : Noxopharm Annual General Meeting Results
Brief: Noxopharm Ltd Says Unit Entered Into A Licence Agreement With Hudson Institute Of Medical Research
Australia Stock Exchange release from NOXOPHARM : Licencing Deal Expands Noxopharm Drug Opportunities
Australia Stock Exchange release from NOXOPHARM : PRE_NR Ends: 09:41:26